Male-specific association between dopamine receptor D4 gene methylation and schizophrenia

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cheng, Jia ^a,b   Wang, Yunliang ^c   Zhou, Kena ^a   Wang, Lingyan ^d   Li, Jinfeng ^c   Zhuang, Qidong ^a   Xu, Xuting ^a   Xu, Leiting ^a   Zhang, Kai ^a   Dai, Dongjun ^a   Zheng, Rongjiong ^a   Li, Guangxue ^a,b   Zhang, Aiping ^e   Gao, Shugui ^b   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b Ningbo Kangning Hospital   (China)

^c The 148th Hospital of PLA   (China)

^d NINGBO NO 2 HOSPITAL   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOPAMINE 4 RECEPTOR; NEUROLEPTIC AGENT; RISPERIDONE; DRD4 PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DRD4 GENE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PATHOGENESIS; PREDICTION; PYROSEQUENCING; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME; YOUNG ADULT; ADOLESCENT; CHILD; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PROMOTER REGION;

ADOLESCENT; ADULT; CHILD; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PROMOTER REGIONS, GENETIC; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA; SEX FACTORS; YOUNG ADULT;

EID: 84896783332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089128     Document Type: Article

References (37)

1. Melas PA, Rogdaki M, Osby U, Schalling M, Lavebratt C, et al. (2012) Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 26: 2712-2718.
2. Association AP (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR.
3. Fanous AH, Kendler KS (2008) Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature. Curr Psychiatry Rep 10: 164-170.
4. Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, et al. (2011) Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res 129: 183-190.
5. Gavin DP, Sharma RP (2010) Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev 34: 882-888.
6. Mellios N, Galdzicka M, Ginns E, Baker SP, Rogaev E, et al. (2012) Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull 38: 433-443.
7. Mulle JG (2012) Schizophrenia genetics: progress, at last. Curr Opin Genet Dev 22: 238-244.
8. Picchioni MM, Murray RM (2007) Schizophrenia. BMJ (Clinical research ed.) 335: 91-95. (Pubitemid 47123289)
9. O'Donovan MC, Williams NM, Owen MJ (2003) Recent advances in the genetics of schizophrenia. Hum Mol Genet 12 Spec No 2: R125-133. (Pubitemid 37259324)
10. Gao S, Hu Z, Cheng J, Zhou W, Xu Y, et al. (2012) Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance. Clin Biochem 45: 787-792.
11. Prata DP, Mechelli A, Fu CH, Picchioni M, Kane F, et al. (2009) Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry 65: 473-480.
12. Barnett JH, Scoriels L, Munafo MR (2008) Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 64: 137-144.
13. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, et al. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614. (Pubitemid 21912282)
14. Andersson RH, Johnston A, Herman PA, Winzer-Serhan UH, Karavanova I, et al. (2012) Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc Natl Acad Sci U S A 109: 13118-13123.
15. Ptacek R, Kuzelova H, Stefano GB (2011) Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders. Medical science monitor : international medical journal of experimental and clinical research 17: RA215-220.
16. Dmitrieva J, Chen C, Greenberger E, Ogunseitan O, Ding YC (2011) Gender-specific expression of the DRD4 gene on adolescent delinquency, anger and thrill seeking. Soc Cogn Affect Neurosci 6: 82-89.
17. Zai CC, Tiwari AK, Basile V, De Luca V, Muller DJ, et al. (2009) Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients. Pharmacogenomics J 9: 168-174.
18. Ekstrom TJ, Lavebratt C, Schalling M (2012) The importance of epigenomic studies in schizophrenia. Epigenomics 4: 359-362.
19. Dong E, Nelson M, Grayson DR, Costa E, Guidotti A (2008) Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci U S A 105: 13614-13619.
20. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, et al. (2008) Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82: 696-711. (Pubitemid 351726115)
21. Bestelmeyer PE, Phillips LH, Crombie C, Benson P, St. Clair D (2009) The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies. Psychiatry Res 169: 212-219.
22. Zhang LN, Liu PP, Wang L, Yuan F, Xu L, et al. (2013) Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PLoS One 8: e63455.
23. Jiang D, Zheng D, Wang L, Huang Y, Liu H, et al. (2013) Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One 8: e59752.
24. Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, et al. (2012) ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 7: 464-472.
25. Chen C, Wang L, Liao Q, Huang Y, Ye H, et al. (2013) Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagn Pathol 8: 199.
26. Bondy B, de Jonge S, Pander S, Primbs J, Ackenheil M (1996) Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J Neuroimmunol 71: 139-144. (Pubitemid 26413266)
27. Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP (2012) An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry 17: 1194-1205.
28. S Docherty JM (2008) Epigenetic mechanisms as mediators of environmental risks for psychiatric disorders. Psychiatry 7: 500-506.
29. Docherty SJ, Davis OS, Haworth CM, Plomin R, D'Souza U, et al. (2012) A genetic association study of DNA methylation levels in the DRD4 gene region finds associations with nearby SNPs. Behav Brain Funct 8: 31.
30. Stahl SM (2010) Fooling mother nature: epigenetics and novel treatments for psychiatric disorders. CNS Spectr 15: 358-365.
31. Lee KY, Joo EJ, Ji YI, Kim DH, Park JB, et al. (2011) Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses. Exp Mol Med 43: 44-52.
32. Okuyama Y, Ishiguro H, Toru M, Arinami T (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 258: 292-295. (Pubitemid 29287044)
33. Pal P, Mihanovic M, Molnar S, Xi H, Sun G, et al. (2009) Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population. Croat Med J 50: 361-369.
34. Lindamer LA, Lohr JB, Harris MJ, Jeste DV (1997) Gender, estrogen, and schizophrenia. Psychopharmacol Bull 33: 221-228. (Pubitemid 27293111)
35. Grigoriadis S, Seeman MV (2002) The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 47: 437-442. (Pubitemid 34792990)
36. Roth TL, Lubin FD, Sodhi M, Kleinman JE (2009) Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 1790: 869-877.
37. Pinsonneault J, Sadee W (2003) Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome. AAPS pharmSci 5(4): E29.